These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31592807)

  • 1. "Pleurex Desalination" in Malignancy-related Ascites: A Novel Mechanism of Hyponatremia.
    Gupta S; McMahon GM; Motwani SS; Mount DB; Waikar SS
    Am J Clin Oncol; 2020 Jan; 43(1):14-19. PubMed ID: 31592807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of Hyponatremia in Patients With Indwelling Peritoneal Catheters for Drainage of Malignant Ascites.
    Gupta S; Tio MC; Gutowski ED; Stecker MS; Verma A; Motwani SS; Mount DB; McMahon GM; Waikar SS
    JAMA Netw Open; 2020 Oct; 3(10):e2017859. PubMed ID: 33104204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
    Ginès P; Wong F; Watson H; Milutinovic S; del Arbol LR; Olteanu D;
    Hepatology; 2008 Jul; 48(1):204-13. PubMed ID: 18508290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
    Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Ohira H
    Intern Med; 2018 Sep; 57(17):2451-2458. PubMed ID: 29607963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyponatremia in liver cirrhosis: pathogenesis and treatment].
    Guevara M; Ginès P
    Endocrinol Nutr; 2010 May; 57 Suppl 2():15-21. PubMed ID: 21130958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].
    Ackermann D
    Ther Umsch; 2009 Nov; 66(11):747-51. PubMed ID: 19885792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyponatremia in the postoperative craniofacial pediatric patient population: a connection to cerebral salt wasting syndrome and management of the disorder.
    Levine JP; Stelnicki E; Weiner HL; Bradley JP; McCarthy JG
    Plast Reconstr Surg; 2001 Nov; 108(6):1501-8. PubMed ID: 11711918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach and management of dysnatremias in cirrhosis.
    Bernardi M; Zaccherini G
    Hepatol Int; 2018 Nov; 12(6):487-499. PubMed ID: 30203382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative hyponatremia despite near-isotonic saline infusion: a phenomenon of desalination.
    Steele A; Gowrishankar M; Abrahamson S; Mazer CD; Feldman RD; Halperin ML
    Ann Intern Med; 1997 Jan; 126(1):20-5. PubMed ID: 8992919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia.
    Wang S; Zhang X; Han T; Xie W; Li Y; Ma H; Liebe R; Weng H; Ding HG
    BMC Gastroenterol; 2018 Sep; 18(1):137. PubMed ID: 30180806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyponatremia in cirrhosis: clinical features and management.
    Martín-Llahí M; Guevara M; Ginès P
    Gastroenterol Clin Biol; 2006 Oct; 30(10):1144-51. PubMed ID: 17075468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Refractory ascites and dilutional hyponatremia: current management and new aquaretics].
    Torre Delgadillo A
    Rev Gastroenterol Mex; 2005; 70(3):299-311. PubMed ID: 17063787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyponatremia in cirrhosis with ascites].
    Bronzi G; Orlando D; De Feudis L; Delle Monache G; Scudieri M; Sergiacomo L; Bernardi M; Pesa O
    Minerva Med; 1990 Sep; 81(9):591-6. PubMed ID: 2234478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of sodium disorders: hyponatremia and hypernatremia.
    Braun MM; Barstow CH; Pyzocha NJ
    Am Fam Physician; 2015 Mar; 91(5):299-307. PubMed ID: 25822386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Etiology, diagnostics and therapy of hyponatremias].
    Laczi F
    Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.
    Kim Y; Lee N; Lee KE; Gwak HS
    Eur J Clin Pharmacol; 2020 May; 76(5):723-729. PubMed ID: 32055900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of ascites and hyponatremia in cirrhosis.
    Ginès P; Cárdenas A
    Semin Liver Dis; 2008 Feb; 28(1):43-58. PubMed ID: 18293276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experience of supplying sodium chloride for the treatment of patients with severe heart failure].
    He LX; Sun LL; Yang YJ; Zhang J; Zhang YH; Song WH; Huang Y; Lü R; Ji SM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Sep; 40(9):766-9. PubMed ID: 23141090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyponatremia in cancer patients].
    Matsuura T
    Nihon Jinzo Gakkai Shi; 2012; 54(7):1016-22. PubMed ID: 23234213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents.
    Leiva JG; Salgado JM; Estradas J; Torre A; Uribe M
    Ann Hepatol; 2007; 6(4):214-21. PubMed ID: 18007550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.